Graded review
Function Health vs InsideTracker: Which Lab-Test Membership Wins?
Function casts a wide 100+ marker net; InsideTracker pairs fewer markers with an algorithm. We grade breadth, actionability, price — and who each fits.
Evidence scorecard
- The one-sentence versionMixed / emerging
- How we score a head-to-headMixed / emerging
- Biomarker breadth: Function wins the count, but the count is mostly framingThin / contested
- Actionability: this is InsideTracker's whole pitch — and its biggest conflictMixed / emerging
- Evidence behind the recommendations: the shared core is solid, the distinctive bits are weakerWell-supported
- Price: different shapes, same lessonMixed / emerging
- The verdict: who each one is forMixed / emerging
- Bottom lineMixed / emerging
The one-sentence version
These two memberships sell opposite philosophies of the same underlying product. Function Health is a wide net — a flat-priced annual panel of 100+ biomarkers, physician-reviewed, that surfaces a lot and tells you to take it to your doctor. InsideTracker is a narrow funnel — smaller panels plus a one-time DNA layer, an algorithmic "InnerAge" number, and a recommendation engine that turns your results into a to-do list. Neither treats you, both share the same cheap outcome-validated core, and the right pick comes down to a single question: do you want more numbers and the freedom to act on them yourself, or fewer numbers wrapped in an algorithm that pushes specific actions back at you? We grade them below on breadth, actionability, the evidence behind the recommendations, and price. For the full single-service write-ups, see our Function Health review and InsideTracker review.
How we score a head-to-head
We hold both services to the same bar we apply everywhere, laid out in how we grade longevity providers: does a feature change an outcome that matters, and is there evidence it does? That keeps us from rewarding the thing each company most wants you to pay for — a big marker count on one side, a proprietary score and personalized product list on the other. The shared, boring truth is that a handful of cheap markers carry almost all the legitimate value on either platform, and the distinctive features are where the price premiums and the cautions live.
Head-to-head
| Function Health | InsideTracker | |
|---|---|---|
| Marker breadth | 100+ baseline panel + retest | Up to ~43-marker 'Ultimate' |
| Price shape | Flat ~$499/yr (current market info) | Premium per marker (current market info) |
| Distinctive layer | Sheer breadth; physician-reviewed | DNA kit + InnerAge + recommendations |
| Actionability | You/your clinician interpret | Algorithm pushes specific actions |
| Useful core | ApoB, Lp(a) once, hs-CRP, HbA1c | ApoB, hs-CRP, HbA1c + deficiency catches |
| Treats results? | No — surfaces and flags | No — scores and recommends |
Biomarker breadth: Function wins the count, but the count is mostly framing
On raw breadth Function is the clear winner — a 100+ baseline panel plus a mid-year retest dwarfs InsideTracker's tiers, which top out around a 43-marker "Ultimate" plan. If your instinct is "more data is better," Function looks like the obvious buy.
The catch is that breadth and value are not the same axis. On both platforms, the markers that actually carry hard-outcome evidence are a short list: a cardiovascular particle count, an inflammation marker, a long-term glucose measure, and a few treatable deficiencies. Function's extra 60-odd line items are largely ordinary bloodwork plus a correlated tail that tracks the cheap core without adding much independent signal — and a couple of its featured markers actively mislead as targets, which we cover in the breadth section below. So Function wins "most markers" decisively while winning "most useful markers" only modestly. InsideTracker tests fewer things but isn't meaningfully shorter on the markers that matter.
Actionability: this is InsideTracker's whole pitch — and its biggest conflict
Here the services genuinely diverge. Function hands you a flagged dashboard and stops; the work of interpreting and acting falls entirely to you and your clinician. InsideTracker instead converts your results into specific nutrition, exercise, and supplement recommendations, and frames a subset of markers as an "InnerAge" you're meant to lower. For a buyer who wants to be told what to do, that is a real, tangible difference in experience.
But actionability cuts both ways, and our grade has to weigh the quality of the actions, not just their presence. The InnerAge score is a proprietary composite of your blood markers — not a validated epigenetic clock, and not something proven to extend life when you push it down. And the recommendation engine carries a built-in conflict: the supplement nudges flow from a company that benefits when you act on them. Function's silence is less satisfying but also less conflicted; InsideTracker's guidance is more useful when it's steering you toward diet and exercise, and more suspect when it's steering you toward a bottle. The honest read: InsideTracker is more actionable, but a meaningful share of those actions aren't outcome-backed.
Evidence behind the recommendations: the shared core is solid, the distinctive bits are weaker
Strip away the framing and the evidence picture is nearly identical at the core. Both surface the markers a standard physical skips and that carry genuine hard-outcome data — ApoB, which counts every atherogenic particle and beats LDL-C as a predictor when the two disagree1; hs-CRP, which predicted first cardiovascular events at least as well as LDL cholesterol in a large prospective study2; and HbA1c, which tracked all-cause and cardiovascular mortality continuously across its range3. That core is real on either platform, and it's cheap.
The divergence is in the distinctive layers. Function's "100+" framing leans on markers that mislead as targets — IGF-1 has a U-shaped mortality relationship in meta-analysis, so "raise it to feel younger" is biologically naïve4, and homocysteine looks treatable until you notice that lowering it with B vitamins failed to cut cardiovascular events in randomized trials5. InsideTracker features the same misleading markers and adds a recommendation engine that can pair them with a supplement suggestion. And it's worth saying plainly that the two largest longevity levers in all of epidemiology — cardiorespiratory fitness, among the strongest survival predictors ever measured6, and grip strength, which outpredicted blood pressure across 17 countries in the PURE study7 — sit on neither dashboard. No membership captures them.
Price: different shapes, same lesson
Function's pricing is its cleanest advantage: a flat annual fee (positioned around $499, current market info) for the broad panel and retest, easy to reason about. InsideTracker prices per marker at a premium and stacks retests across annual plans, so you pay more for fewer markers — the money buys the DNA integration and the recommendation layer, not a longer list. If your only goal is getting the cheap outcome-validated core in front of a clinician, Function delivers more raw testing per dollar, and a focused broad panel can undercut both. We map the price-versus-padding trade across the field in the best longevity blood tests.
The verdict
Verdict: Function for breadth and flat price, InsideTracker for guidance, neither if you just want the core cheaply
- The legitimate value is the same on both — a short list of cheap, outcome-validated markers (ApoB, hs-CRP, HbA1c).
- Function wins breadth and price clarity, but most of the 100+ count is ordinary bloodwork or correlated padding.
- InsideTracker wins actionability, but its supplement nudges carry a built-in conflict and InnerAge is not a validated clock.
- Both feature markers that mislead as targets — IGF-1 (U-shaped mortality) and homocysteine (B-vitamin lowering failed in HOPE-2).
- Neither treats your results, and neither captures fitness or grip strength — the two biggest longevity levers.
The verdict: who each one is for
Neither service "wins" outright because they're solving for different buyers, and both share the category's defining limit — they test, they don't treat.
Pick Function if you're health-literate, want maximum marker breadth at a predictable flat price, and already have a clinician who will act on an abnormal ApoB or HbA1c. You're buying convenience and coverage, and you're comfortable doing the interpretation yourself.
Pick InsideTracker if you specifically value DNA-informed guidance and want the platform to translate results into steps — and you can keep the supplement nudges at arm's length and treat InnerAge as motivation, not a verdict on how fast you're aging.
Pick neither if your real goal is just the cheap actionable core (ApoB, Lp(a) once, hs-CRP, HbA1c) at the lowest price — a focused panel taken to a clinician beats both, and our tools help you estimate what those markers mean before you spend. For the other most-searched matchup against Function's closest price rival, see Function Health vs Superpower.
Bottom line
Function out-tests InsideTracker on breadth and price clarity; InsideTracker out-guides Function on actionability. But the breadth is mostly framing, the guidance is partly conflicted, and the legitimate value — a short list of cheap, outcome-validated markers — is essentially the same on both. Choose Function for coverage and a flat price you'll interpret yourself; choose InsideTracker for hand-holding you'll have to second-guess. Choose neither if you just want the actionable core cheaply, because that's a focused panel and a clinician, not a subscription.
Frequently asked questions
Function Health vs InsideTracker — which is better?
Neither is better outright; they suit different buyers. Function Health offers far more markers (100+) at a flat annual price and leaves interpretation to you and your clinician. InsideTracker tests fewer markers but layers on DNA, an InnerAge score, and personalized recommendations — at a premium per marker. Choose Function for breadth and price clarity, InsideTracker for guidance you can scrutinize. If you only want the cheap actionable core, a focused panel beats both.
Which has more biomarkers, Function Health or InsideTracker?
Function Health, by a wide margin — a 100+ baseline panel plus a retest, versus InsideTracker's tiers that top out around 43 markers. But more markers isn't more health: on both platforms the genuinely useful, outcome-validated markers are a short list (ApoB, hs-CRP, HbA1c plus a few deficiency catches), and much of Function's extra count is ordinary bloodwork or correlated padding that adds little independent signal.
Does either Function Health or InsideTracker treat your results?
No. Both are measurement products, not clinics. Function surfaces results against optimal ranges and stops; InsideTracker surfaces them, scores an InnerAge, and recommends actions — but neither titrates a statin, builds a managed plan, and rechecks. Acting on an abnormal result falls to you and your own clinician on either platform. That test-but-don't-treat structure is the defining limit of the whole direct-to-consumer lab category.
Is InsideTracker's InnerAge or Function's '100+' worth paying extra for?
Both are the marketing headline more than the value. Function's '100+ biomarkers' inflates the count with ordinary bloodwork and a correlated tail, and features markers (IGF-1, homocysteine) that mislead as targets. InsideTracker's InnerAge is a proprietary composite of your blood markers, not a validated epigenetic clock or a target proven to extend life when lowered. The real value on either platform is the cheap outcome-validated core, not the distinctive feature you're paying a premium for.
References
- Glavinovic T, Thanassoulis G, de Graaf J, et al. (2022). Physiological Bases for the Superiority of Apolipoprotein B Over Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk. Journal of the American Heart Association. https://pubmed.ncbi.nlm.nih.gov/36216435/
- Ridker PM, Rifai N, Rose L, et al. (2002). Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/12432042/
- Khaw KT, Wareham N, Luben R, et al. (2001). Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk). BMJ. https://pubmed.ncbi.nlm.nih.gov/11141143/
- Burgers AM, Biermasz NR, Schoones JW, et al. (2011). Meta-analysis and dose-response metaregression: circulating insulin-like growth factor I (IGF-I) and mortality. Journal of Clinical Endocrinology & Metabolism. https://pubmed.ncbi.nlm.nih.gov/21795450/
- Lonn E, Yusuf S, Arnold MJ, et al. (2006). Homocysteine lowering with folic acid and B vitamins in vascular disease (HOPE-2). New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/16531613/
- Mandsager K, Harb S, Cremer P, et al. (2018). Association of Cardiorespiratory Fitness With Long-term Mortality Among Adults Undergoing Exercise Treadmill Testing. JAMA Network Open. https://pubmed.ncbi.nlm.nih.gov/30646252/
- Leong DP, Teo KK, Rangarajan S, et al. (2015). Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet. https://pubmed.ncbi.nlm.nih.gov/25982160/
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
More graded reviews
Longevity Medicine: What's Proven vs Hyped
An honest, evidence-graded tour of the longevity toolkit — what has human outcome RCTs versus what is animal or mechanistic-only.
ReadDo NAD+ and Peptides Actually Extend Lifespan?
NAD+ precursors reliably raise NAD+ but show modest, mixed human outcomes. Peptides and growth hormone carry real cautions. An honest evidence review.
ReadRapamycin & Metformin for Longevity: The Evidence
Strong animal data, a glaring human RCT gap. What the PEARL pilot, the TAME rationale, and metformin's observational signal really show.
ReadAre Longevity Clinics Worth It?
DTC and IV longevity clinics sit on the weakest evidence in the field. What a critical review found, and how to vet a provider before paying.
ReadRapamycin for Longevity: Hype vs Evidence
Rapamycin is the most reproducible lifespan extender in mice — but there is no human longevity trial. An honest split of the hype from the evidence.
ReadWhat the PEARL Trial Actually Showed About Rapamycin
PEARL was the largest decentralized RCT of rapamycin in healthy aging — and it missed its primary endpoint. An honest readout of what it did and didn't prove.
ReadLongevity Clinics vs Lab Memberships vs Rx Telehealth: What Each Delivers
The longevity market splits into four bands: concierge clinics, membership programs, DTC labs, single-product Rx. What each delivers, and who it's for.
ReadBiological Age Tests: Do Epigenetic Clocks Actually Work?
Epigenetic clocks (Horvath, GrimAge, DunedinPACE) predict aging well in populations — but are noisy and unproven for individuals. An honest evidence review.
ReadNAD+ for Longevity: What the Trials Actually Show
NR and NMN reliably raise NAD+ in humans, but the trials mostly fail to show clinical or longevity outcomes. An honest review of the hype versus the data.
ReadWhat Do Longevity Biomarker Panels Actually Test?
Longevity panels mix genuinely useful, outcome-validated markers (ApoB, HbA1c, hs-CRP) with vanity numbers. An honest, evidence-graded breakdown.
ReadGLP-1s for Healthspan & Longevity: The Evidence
GLP-1 drugs have the strongest human outcome data in longevity — but it's cardiometabolic risk reduction, not proven lifespan extension. An honest review.
ReadPeptides for Longevity: What's Real and What's Marketing
Most longevity peptides are sold on mechanism and anecdote, not human outcomes. An honest, citation-backed review of what the evidence actually supports.
ReadMetformin for Longevity: The TAME Trial Evidence
Metformin's anti-aging case is mechanistic and observational — no completed RCT proves it. Why the TAME trial exists, and the exercise caveat.
ReadConcierge vs Membership Longevity: What You Actually Get
Concierge clinics ($8k–$25k/yr) sell diagnostics; membership programs ($99–$300/mo) sell ongoing treatment. What each delivers, and where the money goes.
ReadHow We Grade Longevity Providers: Our Methodology
The five-axis rubric behind our longevity provider rankings: oversight, evidence honesty, transparency, price, and conflicts of interest.
ReadBest Longevity Supplements, Rated by Evidence (2026)
We grade the popular longevity supplements — NMN, NR, spermidine, resveratrol, CoQ10, omega-3, vitamin D, fisetin, GlyNAC — on human evidence, not hype.
ReadWhat Is a Longevity Doctor (and Do You Need One)?
A longevity doctor blends preventive medicine, biomarker testing, and lifestyle coaching. What they really do, credentials to check, and who needs one.
ReadSpermidine for Longevity: What the Evidence Shows
Spermidine induces autophagy and dietary intake tracks with lower mortality — but the best human trial was negative. An honest, evidence-graded review.
ReadThe Sitting-Rising Test & Longevity: What the Evidence Actually Shows
The sitting-rising and sit-to-stand tests predict mortality in research — but they're markers of strength, balance, and flexibility, not a verdict.
ReadHow Much Does a Longevity Clinic Cost?
Longevity care runs from ~$200/yr lab memberships to $20k+ concierge programs. A 2026 price-band guide to what each tier buys — and what's worth paying for.
ReadFree Biological-Age Tests & Calculators: Do They Actually Work?
Free biological-age calculators range from validated (PhenoAge from a basic blood panel) to entertainment. An honest guide to what's worth your time.
ReadTaurine for Longevity: Does the 2023 Science Study Hold Up?
A 2023 Science paper called taurine deficiency a driver of aging. A 2025 Science follow-up questioned its core premise. An honest, evidence-graded review.
ReadUrolithin A (Mitopure): Mitochondrial Hype or Real?
Urolithin A (Mitopure) has the cleanest human-trial record of any mitochondrial supplement — modest muscle gains in RCTs. But healthspan isn't lifespan.
ReadFisetin as a Senolytic: What "Hit-and-Run" Dosing Shows
Fisetin was the standout senolytic flavonoid in mouse screens and extended lifespan ~10%. In humans, the longevity data are essentially zero. An honest review.
ReadGlyNAC (Glycine + NAC) for Aging: What the Baylor Trials Actually Show
Baylor RCTs report GlyNAC corrects glutathione deficiency and several aging hallmarks in older adults. But the trials are small and the headlines overstate it.
ReadAlpha-Ketoglutarate (Rejuvant/AKG): Does the "8 Years Younger" Claim Hold Up?
The viral "8 years younger" AKG result came from a 42-person study with no placebo group and an unvalidated aging clock. An honest evidence review.
ReadDasatinib + Quercetin: How Far Along Is the Flagship Senolytic?
Dasatinib + quercetin is the first-in-human senolytic — with small IPF and kidney signals. But it's a chemo drug plus a flavonoid, with no longevity RCT yet.
ReadTruDiagnostic TruAge Review: Is the $229 Epigenetic Clock Worth It?
TruDiagnostic's TruAge uses the well-validated DunedinPACE clock — but no test proves the score predicts YOUR outcomes. An honest, evidence-graded review.
ReadFunction Health Review: Are 100+ Biomarkers Worth $499/yr?
Function Health's 100+ lab membership surfaces real outcome-validated markers — but roughly half are basic labs, and it tests without treating. Honest review.
ReadBryan Johnson's Blueprint Review: Evidence vs N-of-1 Hype
Bryan Johnson's Blueprint is a single-subject experiment with no control group — and roughly 90% of its likely benefit is replicable diet, sleep, and exercise.
ReadVO2 Max and Longevity: The Strongest Fitness Predictor of Lifespan
Cardiorespiratory fitness is one of the best-validated predictors of mortality — low fitness carries risk on par with smoking, and it's trainable.
ReadGrip Strength as a Longevity Biomarker: What the Evidence Shows
In the 140,000-person PURE study, grip strength outpredicted systolic blood pressure for mortality. A genuinely strong, free, at-home biomarker.
ReadFasting-Mimicking Diet (ProLon) Review: Does the Evidence Hold Up?
ProLon's 5-day fasting-mimicking diet has real human trials behind it — but most are tied to its inventor's company. An honest, graded look.
ReadHyperbaric Oxygen for Aging: Does the Telomere Claim Hold Up?
One small Israeli trial reported HBOT lengthened telomeres 38% and cut senescent cells. It's striking, unreplicated, and expensive. An honest, graded review.
ReadCreatine for Aging: The Cheapest Evidence-Backed Supplement?
Creatine has the strongest human evidence of any longevity supplement — for healthspan, not lifespan. With resistance training it adds muscle and strength.
ReadThe Hallmarks of Aging, Explained (and Why They Matter)
The hallmarks of aging are the cellular processes that drive getting old. A plain-English guide to the 2013 and 2023 framework — and why each one gets targeted.
ReadSulforaphane for Longevity: Promising Biology, Preclinical Proof
Sulforaphane from broccoli extends lifespan in worms and activates Nrf2 — but the human longevity evidence is preclinical. An honest, evidence-graded review.
ReadGlycine for Longevity: The Other Half of GlyNAC
Glycine alone extended mouse lifespan ~6% in the ITP. But the dramatic 'reverses aging' results belong to the GlyNAC combo, not solo glycine. An honest review.
ReadMicrodose Lithium for Longevity & Brain Aging: The Evidence
A 2025 Nature study tied lithium deficiency to Alzheimer's in mice. But that's mouse healthspan, not human lifespan — and lithium has a narrow safety window.
ReadErgothioneine: The "Longevity Vitamin"? An Evidence-Graded Review
Ergothioneine has a strong observational link to lower mortality — but no human trial, and the signal may just track a healthy diet. An honest grade.
ReadOmega-3 for Longevity: What the DO-HEALTH Trial Actually Shows
DO-HEALTH found 1 g/day omega-3 slowed epigenetic clocks by ~3–4 months. Real, randomized — but a small, surrogate effect. An honest evidence grade.
ReadCoQ10 & Ubiquinol for Aging: What the Evidence Actually Shows
KiSel-10 showed CoQ10 plus selenium cut cardiovascular mortality in elderly Swedes — but the benefit is CV-specific, not lifespan. An honest grade.
ReadBest Epigenetic Clock: GrimAge vs PhenoAge vs DunedinPACE
GrimAge predicts mortality, PhenoAge predicts disease, DunedinPACE measures pace of aging. No clock is validated to guide your treatment. An honest comparison.
ReadGlycanAge Review: Is the Glycan Aging Test Worth It?
GlycanAge measures IgG glycans tied to inflammation, and they move with lifestyle — but independent validation is thin and it can't localize a problem. Graded.
ReadGalleri Multi-Cancer Test Review: Is It Worth It?
Galleri's blood test can flag a cancer signal across many types — but no trial shows it saves lives, and false positives trigger costly cascades. Graded.
ReadFountain Life vs Human Longevity Inc: MRI Clinics Compared
Two whole-body-MRI longevity clinics compared. The headline isn't the price — it's the incidentaloma problem: most scary scan findings turn out to be nothing.
ReadSauna & Longevity: What the Finnish Studies Actually Show
Frequent sauna use is tied to ~40% lower all-cause mortality in Finnish men — but it's one observational cohort, not a randomized trial. An honest grade-B read.
ReadCold Plunge for Longevity: Hype vs Evidence
Cold exposure extends lifespan in worms and flies — but there's zero human lifespan data, and the human evidence is about recovery and mood, not living longer.
ReadZone 2 Training for Longevity: The Evidence, Graded Honestly
Zone 2 has a strong mitochondrial mechanism and builds the fitness that predicts lifespan — but no trial proves Zone 2 itself extends life. Graded honestly.
ReadOutlive by Peter Attia: An Evidence-Based Review
Attia's Outlive popularized Medicine 3.0 and the Four Horsemen. We grade the framework honestly: where the evidence is strong, and where it's reasoned opinion.
ReadBest Longevity Blood Test Services, Compared (2026)
Function, InsideTracker, Lifeforce, Superpower — graded honestly. The four cheap outcome-validated markers matter; the '100+ biomarker' count mostly doesn't.
ReadBest At-Home Biological Age Test (2026): Honestly Graded
Blood-methylation clocks are the only defensible at-home bio-age tier; saliva and telomere kits are noisier. None proves you're aging slower. Honestly graded.
ReadInsideTracker Review: Worth It in 2026?
InsideTracker adds DNA and an 'InnerAge' score to blood panels. The core markers are real, but it's pricier per marker and recommendations skew to upsells.
ReadLifeforce Review: Is the Membership Worth It?
Lifeforce bundles a clinician and Rx onto a ~50-marker quarterly panel for ~$129/mo. That crosses test-into-treat — but the panel is narrow and the upsell real.
ReadDoes Resveratrol Actually Work for Longevity?
A skeptical, evidence-graded review: the SIRT1 story was an artifact, a 2025 primate trial found no lifespan benefit, and oral resveratrol barely reaches cells.
ReadCollagen for Aging: What the Evidence Says
Industry-funded trials show skin and joint benefits; independent reviews are cautious. Collagen digests to amino acids, and the longevity claim is unproven.
ReadQuercetin for Longevity: Senolytic Hype vs Evidence
Quercetin's senolytic effect needs the dasatinib combination. Standalone quercetin has no human senolytic evidence — just modest anti-inflammatory effects.
ReadSuperpower Health Review: Is the $499 100-Lab Membership Worth It?
Superpower's $499/yr 100+ lab membership is slick and cheap-per-marker — but it tests without treating, and the panel leans on padding. Honest, graded review.
ReadFunction Health vs Superpower: Which Lab Membership Wins?
Function Health vs Superpower, graded honestly: nearly identical 100+ lab memberships that both test without treating. The tiebreaker isn't the marker count.
ReadNOVOS Core Review: Does the 12-Ingredient Longevity Drink Work?
NOVOS Core bundles 12 longevity ingredients into one daily drink. The formulation logic is real; the human lifespan proof isn't. An honest, graded review.
ReadTally Health Review: Is the TruAge Epigenetic Membership Worth It?
Tally Health pairs a TruAge epigenetic-age test with coaching and a supplement. The clock is real science; tracking your own aging with it isn't proven.
ReadNOVOS vs Tally Health: Which Longevity Brand Is Worth It?
NOVOS sells a multi-pathway longevity supplement; Tally Health sells an epigenetic-age test plus its own pill. A graded, honest head-to-head on what's proven.
ReadSpermidine vs Fisetin: Two Longevity Supplements, Honestly Compared
Spermidine targets autophagy; fisetin clears senescent cells. Different mechanisms, different evidence grades — an honest, head-to-head longevity comparison.
ReadGlycine vs GlyNAC: Is Adding NAC Worth It for Longevity?
GlyNAC adds N-acetylcysteine to glycine for glutathione restoration. Is the extra ingredient worth it for longevity? An honest, graded comparison.
Read